May 2023 FDA Recall Pain Reliever by Aurobindo Pharma Usa Inc.
D-0765-2023 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Aurobindo Pharma Usa Inc. on May 22, 2023 for the product Pain Reliever. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0765-2023

Reason for Recall
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
Initiated
05-22-2023
Reported
05-31-2023
Quantity
87,360 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Aurobindo Pharma USA Inc.
The recalled product was distributed to one Retail Distributor (Walgreens) who further distributed Nationwide in the USA.
Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35.

Batch or Lot Expiration Information

Lot# Lot: P2200101, P2200178, Exp. date 11/2023; P2200230, Exp. date 12/2023